Theranostic nanoparticles for future personalized medicine.

  title={Theranostic nanoparticles for future personalized medicine.},
  author={Ju Hee Ryu and Sangmin Lee and Sohee Son and Sun Hwa Kim and James F. Leary and Kuiwon Choi and Ick Chan Kwon},
  journal={Journal of controlled release : official journal of the Controlled Release Society},
  • J. Ryu, Sangmin Lee, I. Kwon
  • Published 28 September 2014
  • Biology, Medicine, Psychology
  • Journal of controlled release : official journal of the Controlled Release Society

Figures from this paper

Gold nanoparticle-based theranostics: disease diagnostics and treatment using a single nanomaterial
The multifunctionality of gold nanoparticles as theranostics agents will be highlighted, as well as the requirements before the translation of these nanoplatforms into routine clinical practice.
Multifunctional nanoparticles for use in theranostic applications
This review gives a brief overview of the components of a theranostic system and the challenges that designing truly multifunctional nanoparticles present.
Clinical advances of nanocarrier-based cancer therapy and diagnostics
F multifunctional nanosystems with both imaging and therapy functionalities bring us a step closer to delivering precision/personalized medicine in the cancer setting.
Gold Nanotheranostics: Proof-of-Concept or Clinical Tool?
This review focuses on gold nanoparticle-based theranostics at the lab bench, through pre-clinical and clinical stages, and discusses the efforts currently being made to translate nanotheranostics into the market, as well as their commercial impact.
Applications of nanoparticles in cancer medicine and beyond: optical and multimodal in vivo imaging, tissue targeting and drug delivery
This review article summarizes the advances in the engineering of NPs for biomedical applications, from optical imaging (OI) to multimodal OI and targeted drug delivery and provides some examples of how investigations in nanomedicine can support preclinical and clinical research generating innovative diagnostic and therapeutic strategies in oncology.
Cancer‐Associated, Stimuli‐Driven, Turn on Theranostics for Multimodality Imaging and Therapy
The fundamental backgrounds of diagnostic and therapeutic tools that have been widely utilized for developing theranostic agents are provided and the current approaches for developing stimuli‐responsive turn on theranostics are discussed.
Theranostic Nanoparticles for Tracking and Monitoring Disease State
This review focuses on state-of-the-art theranostic nanoparticles that are capable of both delivering therapy and self-reporting/tracking disease through imaging and the opportunity to rapidly adjust treatment for individualized medicine.


Nanotheranostics for personalized medicine.
Development and applications of photo-triggered theranostic agents.
Nanotheranostics for personalized medicine
Current nanotechnology-based theranostics systems engineered for PM applications are not yet sufficient, and the authors dissect the requirements for successful nanotheranostics-based PM.
Imaging and drug delivery using theranostic nanoparticles.
Biomedical nanomaterials for imaging-guided cancer therapy.
To date, even though various kinds of nanomaterials have been evaluated over the years in order to develop effective cancer therapy, there is still significant challenges in the improvement of the
In vivo targeted delivery of nanoparticles for theranosis.
This Account develops a glycol chitosan nanoparticle (CNP), which is suitable for angiogenic diseases, such as cancers, even without an additional targeting moiety, and develops hyaluronic acid nanoparticles that can bind efficiently to the CD44 antigen receptors abundant in many tumor cells.
Nanoparticle therapeutics for prostate cancer treatment.
  • V. Sanna, M. Sechi
  • Biology, Medicine
    Nanomedicine : nanotechnology, biology, and medicine
  • 2012
Nanotheranostics – a review of recent publications
An extensive review, from a chemistry point of view, of the recent development of nanotheranostics and its in vitro and in vivo applications are presented.
Molecular imaging with theranostic nanoparticles.
Diagnosis imaging and therapeutic uses of NPs are described and examples of five primary types of nanoparticles with concurrent diagnostic and therapeutic use are proposed.